METHODS AND COMPOSITIONS FOR IMAGING MALIGNANCIES IN THE BONE MARROW

Abstract

Compositions, methods of synthesis, and methods of use for an imaging agent that preferentially binds to activated VLA4, including, but not limited to a peptide or peptidomimetic ligand radiolabeled for use in PET imaging to identify bone marrow malignancies, help select treatments for bone marrow malignancies, and monitor relapse in bone marrow malignancy patients after therapy are disclosed.

CPC Classifications